Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04836884 · ClinicalTrials.gov registry record · NA
Vascular Anomaly Pathology and Genomics Biopsy Study
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 3
- Enrollment target
NCT04836884: Completed NA study, sponsored by Mayo Clinic.
NCT04836884 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 3 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04836884, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
Study Summary
The purpose of this research is to gather information on the safety and effectiveness of core biopsy of vascular anomalies for clinical pathology and clinical genomics studies.
Interventions
- PROCEDURE Percutaneous Vascular Anomaly/Malformation Biopsy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2021-04-06 |
| Est. Completion | 2022-01-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04836884
The ClinicalTrials.gov registry entry for NCT04836884 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Percutaneous Vascular Anomaly/Malformation Biopsy is the first listed.
NCT04836884 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04836884 about?
NCT04836884 is a clinical study titled "Vascular Anomaly Pathology and Genomics Biopsy Study". The purpose of this research is to gather information on the safety and effectiveness of core biopsy of vascular anomalies for clinical pathology and clinical genomics studies.
What is the current status of trial NCT04836884?
This trial is currently completed. It is a NA study. The enrollment target is 3 participants. The study started on 2021-04-06. Estimated completion is 2022-01-31.
What interventions are being tested in trial NCT04836884?
The interventions under investigation include: Percutaneous Vascular Anomaly/Malformation Biopsy (PROCEDURE).
Who is sponsoring clinical trial NCT04836884?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.